Skip to content

Strategy to recognize and initiate treatment of chronic heart failure (STRETCH).

A combined diagnostic-therapeutic strategy to optimize management of patients with previously unrecognized heart failure in primary care.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20397
Enrollment
1500
Registered
2010-09-01
Start date
2010-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Training of general practitioners in up-titration of heart failure medication. General practitioners in the intervention group will receive a single training of 2 hours from a cardiologist. The uptitr

Sponsors

University Medical Center Utrecht (UMCU)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 65 years or over; 2. Shortness of breath as reason for GP contact in the previous 12 months.

Exclusion criteria

Exclusion criteria: 1. Already established heart failure, that is a diagnosis of heart failure confirmed by the cardiologist with echocardiography; 2. A life expectancy shorter than 6 months; 3. Not being able to give informed consent.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the diagnostic part of our combined diagnostic-therapeutic strategy is: 1. Prevalence of 'systolic' and 'diastolic' heart failure in elderly who presented to the general practitioner with shortness of breath on exertion. The primary outcomes of the therapeutic part of our combined diagnostic-therapeutic strategy are: 1. Differences in prescription of ACE-inhibitors and beta-blockers between the intervention and control group after 6 months follow-up; 2. Differences in quality of life between patients in the two groups after 6 months follow-up.

Secondary

MeasureTime frame
1. Differences in heart failure related doctor-appointments and hospitalization rates between the intervention and control group during 6 months follow-up; 2. Cost-effectiveness of the implemented diagnostic-therapeutic strategy.

Contacts

Public ContactEvelien E.S. Riet, van

Stratenum 5.143

E.E.S.vanRiet@umcutrecht.nl+31 (0)6 0887568363

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)